31 – 40 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Smoking impacts endogenous estradiol and testosterone levels in young healthy women
2017) American Association for Cancer Research (AACR) 108th Annual Meeting 2017 In Cancer Research 77(13 Suppl).(
- Contribution to journal › Published meeting abstract
-
Mark
Body constitution in young healthy women from breast cancer higher risk families in relation to smoking
2017) American Association for Cancer Research (AACR) 108th Annual Meeting 2017 In Cancer Research 77(13).(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
CYP1A2 - a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
(
- Contribution to journal › Article
-
Mark
Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
(
- Contribution to journal › Article
- 2015
-
Mark
Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.
(
- Contribution to journal › Article
-
Mark
Caffeine and caffeic acid inhibit growth and modify estrogen receptor (ER) and insulin-like growth factor I receptor (IGF-IR) levels in human breast cancer.
(
- Contribution to journal › Article
-
Mark
History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response.
(
- Contribution to journal › Article
- 2014
-
Mark
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events.
(
- Contribution to journal › Article
-
Mark
No association found between CYP2D6 genotype and early breast cancer events in tamoxifen-treated patients.
(
- Contribution to journal › Article
-
Mark
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
(
- Contribution to journal › Article